Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

Presentation TCT 2017

Insights From the New 2017 ESC Valve Disease Guidelines: Changes in the Management of Aortic Stenosis

Presenter: Martin B. Leon, Patrick T. O'Gara, Olaf Wendler

October 30, 2017

Presentation TCT 2014

Lessons from the First Round of Transcatheter Mitral Valve Implants and Constructive Suggestions for the Future

Presenter: Craig R. Smith, Alec S. Vahanian, Olaf Wendler, Alfredo Trento

September 14, 2014

Presentation TCT 2014

Tendyne: Design, Clinical Results, and Next Steps

Presenter: Craig R. Smith, Alec S. Vahanian, Olaf Wendler, Paul A. Grayburn

September 14, 2014

Presentation TCT 2014

Neovasc Tiara: Design, Clinical Results, and Next Steps

Presenter: Craig R. Smith, Alec S. Vahanian, Olaf Wendler, Anson Cheung

September 14, 2014

Presentation TCT 2014

Edwards Fortis: Design, Clinical Results, and Next Steps

Presenter: Craig R. Smith, Alec S. Vahanian, Olaf Wendler, Vinayak Bapat

September 14, 2014

Presentation TCT 2014

CardiaQ: Design, Clinical Results, and Next Steps

Presenter: Craig R. Smith, Alec S. Vahanian, Olaf Wendler, Lars Sondergaard

September 14, 2014

Presentation TCT 2014

Hurdles That Must Be Overcome in Designing and Implanting a Transcatheter Mitral Valve: Caveat Emptor! Insights from a Cardiac Surgeon

Presenter: Craig R. Smith, Alec S. Vahanian, Olaf Wendler, Neil E. Moat

September 14, 2014

Presentation TCT 2014

Perspectives from Valve-in-Ring Experiences (Transfemoral)

Presenter: Craig R. Smith, Alec S. Vahanian, Olaf Wendler, Dominique Himbert

September 14, 2014

Presentation TCT 2014

Perspectives from Valve-in-Ring Experiences (Transapical)

Presenter: Craig R. Smith, Alec S. Vahanian, Olaf Wendler, Anson Cheung

September 14, 2014

Presentation TCT 2014

Perspectives from Valve-in-Valve Experiences

Presenter: Craig R. Smith, Alec S. Vahanian, Olaf Wendler, Danny Dvir

September 14, 2014

Presentation TVT 2014

Yes, Clearly!

Presenter: Olaf Wendler

June 07, 2014

Presentation TVT 2014

Very Frequently!

Presenter: Olaf Wendler

June 05, 2014

Presentation TCT 2013

Transcatheter Replacement!

Presenter: Olaf Wendler

October 28, 2013

Presentation TCT 2013

Important Updates from the Edwards SAPIEN (and XT) SOURCE Registries

Presenter: Olaf Wendler

October 28, 2013

Presentation TVT 2013

Are There Indications for Direct Surgical Femoral Artery Cutdown and Repair?

Presenter: Olaf Wendler

June 12, 2013

Presentation TVT 2012

When Transfemoral Is Possible, When Is Alternative Access Preferred(2)

Presenter: Olaf Wendler

June 05, 2012

Presentation TVT 2012

The Multicenter SOURCE TAVR Registry (Including XT)

Presenter: Olaf Wendler

June 05, 2012

Presentation TVT 2012

EU Insights on Withholding TAVR in Futile Patients(2)

Presenter: Olaf Wendler

June 05, 2012

Presentation TVT 2012

A "Maximalist" Approach Is Best: TEE, General Anesthesia, and On-site Surgical Involvement

Presenter: Olaf Wendler

June 03, 2012

Presentation EuroPCR 2012

30 Day Outcomes from the SOURCE XT TAVI Post Approval Study

Presenter: 203692|Olaf Wendler

May 18, 2012

Advertisement

Insights From the New 2017 ESC Valve Disease Guidelines: Changes in the Management of Aortic Stenosis

Lessons from the First Round of Transcatheter Mitral Valve Implants and Constructive Suggestions for the Future

Tendyne: Design, Clinical Results, and Next Steps

Neovasc Tiara: Design, Clinical Results, and Next Steps

Edwards Fortis: Design, Clinical Results, and Next Steps

CardiaQ: Design, Clinical Results, and Next Steps

Hurdles That Must Be Overcome in Designing and Implanting a Transcatheter Mitral Valve: Caveat Emptor! Insights from a Cardiac Surgeon

Perspectives from Valve-in-Ring Experiences (Transfemoral)

Perspectives from Valve-in-Ring Experiences (Transapical)

Perspectives from Valve-in-Valve Experiences

Yes, Clearly!

Very Frequently!

Transcatheter Replacement!

Important Updates from the Edwards SAPIEN (and XT) SOURCE Registries

Are There Indications for Direct Surgical Femoral Artery Cutdown and Repair?

When Transfemoral Is Possible, When Is Alternative Access Preferred(2)

The Multicenter SOURCE TAVR Registry (Including XT)

EU Insights on Withholding TAVR in Futile Patients(2)

A "Maximalist" Approach Is Best: TEE, General Anesthesia, and On-site Surgical Involvement

30 Day Outcomes from the SOURCE XT TAVI Post Approval Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content